BACKGROUND: Maternal obesity represents a risk factor for pregnancy-related complications. Glucocorticoids are known to promote obesity in adults. METHODS: We evaluated maternal and fetal metabolic changes during and after 3 weekly courses of betamethasone administered to pregnant baboons (Papio subspecies) at doses equivalent to those given to pregnant women. RESULTS: Betamethasone administration during the second half of pregnancy increased maternal weight but neither maternal food intake nor fetal weight, as assessed at the end of gestation. Betamethasone increased maternal serum glucose concentration, the ratio of insulin-like growth factor-I and insulin-like growth factor binding protein-3, and serum leptin during treatment (normalized by 17, 35, and 45 days posttreatment, respectively, for each parameter). Maternal and fetal serum leptin concentrations did not differ between groups at the end of gestation. CONCLUSION: Prolonged maternal hyperleptinemia caused by betamethasone administration in the second half of gestation did not change fetal metabolic parameters measured and placental leptin distribution at the end of gestation.
BACKGROUND:Maternal obesity represents a risk factor for pregnancy-related complications. Glucocorticoids are known to promote obesity in adults. METHODS: We evaluated maternal and fetal metabolic changes during and after 3 weekly courses of betamethasone administered to pregnant baboons (Papio subspecies) at doses equivalent to those given to pregnant women. RESULTS:Betamethasone administration during the second half of pregnancy increased maternal weight but neither maternal food intake nor fetal weight, as assessed at the end of gestation. Betamethasone increased maternal serum glucose concentration, the ratio of insulin-like growth factor-I and insulin-like growth factor binding protein-3, and serum leptin during treatment (normalized by 17, 35, and 45 days posttreatment, respectively, for each parameter). Maternal and fetal serum leptin concentrations did not differ between groups at the end of gestation. CONCLUSION: Prolonged maternal hyperleptinemia caused by betamethasone administration in the second half of gestation did not change fetal metabolic parameters measured and placental leptin distribution at the end of gestation.
Authors: N E Schlabritz-Loutsevitch; G B Hubbard; M J Dammann; S L Jenkins; P A Frost; T J McDonald; P W Nathanielsz Journal: J Med Primatol Date: 2004-06 Impact factor: 0.667
Authors: D Farley; M E Tejero; A G Comuzzie; P B Higgins; L Cox; S L Werner; S L Jenkins; C Li; J Choi; E J Dick; G B Hubbard; P Frost; D J Dudley; B Ballesteros; G Wu; P W Nathanielsz; N E Schlabritz-Loutsevitch Journal: Placenta Date: 2009-07-25 Impact factor: 3.481
Authors: Laura A Cox; Anthony G Comuzzie; Lorena M Havill; Genesio M Karere; Kimberly D Spradling; Michael C Mahaney; Peter W Nathanielsz; Daniel P Nicolella; Robert E Shade; Saroja Voruganti; John L VandeBerg Journal: ILAR J Date: 2013
Authors: Yugendar R Bommineni; Edward J Dick; Adinarayana R Malapati; Michael A Owston; Gene B Hubbard Journal: J Med Primatol Date: 2011-01-13 Impact factor: 0.667
Authors: Jesse S Rodriguez; Thad Q Bartlett; Kathryn E Keenan; Peter W Nathanielsz; Mark J Nijland Journal: Reprod Sci Date: 2012-02-16 Impact factor: 3.060
Authors: Cun Li; Emma Ramahi; Mark J Nijland; Jaeyhek Choi; Dean A Myers; Peter W Nathanielsz; Thomas J McDonald Journal: Endocrinology Date: 2013-04-26 Impact factor: 4.736
Authors: Jesse S Rodriguez; Nicole R Zürcher; Kathryn E Keenan; Thad Q Bartlett; Peter W Nathanielsz; Mark J Nijland Journal: Am J Obstet Gynecol Date: 2011-03-16 Impact factor: 8.661
Authors: Hillary F Huber; Anderson H Kuo; Cun Li; Susan L Jenkins; Kenneth G Gerow; Geoffrey D Clarke; Peter W Nathanielsz Journal: Reprod Sci Date: 2018-06-05 Impact factor: 3.060
Authors: Lina Gubhaju; Megan R Sutherland; Bradley A Yoder; Anthony Zulli; John F Bertram; M Jane Black Journal: Am J Physiol Renal Physiol Date: 2009-09-16